Skip to main content

and
  1. No Access

    Article

    Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil

    Arginase 1 (ARG1) and arginase 2 (ARG2) compete with nitric oxide synthases for the substrate l-arginine. Here we aim to assess whether arginase 1 and 2 plasma levels, plasma arginase activity or genetic factors ...

    R Lacchini, J J Muniz, Y T D A Nobre, A J Cologna in The Pharmacogenomics Journal (2018)

  2. No Access

    Article

    Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

    Nicotinamide phosphorybosil transferase (NAMPT) polymorphisms affect visfatin/NAMPT levels and may affect the responsiveness to therapy in hypertensive disorders of pregnancy. We examined whether NAMPT polymorphi...

    M R Luizon, A C T Palei, V A Belo, L M Amaral, R Lacchini in The Pharmacogenomics Journal (2017)

  3. No Access

    Article

    In reply to: Enalapril and the VEGFA gene: personalized medicine in hypertension therapy

    G. H. Oliveira-Paula, R. Lacchini in European Journal of Clinical Pharmacology (2016)

  4. No Access

    Article

    Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril

    Vascular endothelial growth factor (VEGF) is a potent angiogenic factor that affects blood pressure by promoting vasodilation mediated by nitric oxide. Angiotensin-converting enzyme inhibitors (ACEi) up-regula...

    G. H. Oliveira-Paula, R. Lacchini, V. Fontana in European Journal of Clinical Pharmacology (2015)

  5. Article

    Erratum: The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents

    Correction to: Journal of Human Hypertension advance online publication, 19 June 2014; doi:10.1038/jhh.2014.48 The author JT Sertorio was omitted from the author list. This has now been rectified and the corre...

    J A de Miranda, R Lacchini, V A Belo, C M M Lanna in Journal of Human Hypertension (2015)

  6. No Access

    Article

    The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents

    Obesity and the nitric oxide synthase 3 (NOS3) gene polymorphisms are associated with nitrite levels and hypertension. However, no study has tested the hypothesis that NOS3 tagSNPs rs3918226, rs3918188, rs7435...

    J A de Miranda, R Lacchini, V A Belo, C M M Lanna in Journal of Human Hypertension (2015)

  7. No Access

    Article

    The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity

    Polymorphisms in the NAMPT gene, which encodes the adipocytokine visfatin/nicotinamide phosphorybosil transferase (NAMPT), affect the circulating visfatin/NAMPT levels and are associated with obesity and cardiova...

    V A Belo, M R Luizon, R Lacchini, J A Miranda in International Journal of Obesity (2015)

  8. No Access

    Article

    Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

    Tissue inhibitor of metalloproteinase (TIMP)-1 is a major endogenous inhibitor of matrix metalloproteinase (MMP)-9, which may affect the responsiveness to therapy in hypertensive disorders of pregnancy. We examin...

    M R Luizon, A C T Palei, V C Sandrim, L M Amaral in The Pharmacogenomics Journal (2014)

  9. No Access

    Article

    VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction

    Vascular endothelial growth factor (VEGF) is a cytokine involved in angiogenesis and is closely related to the nitric oxide–cyclic guanosine monophosphate pathway, a target for sildenafil. We investigated for ...

    R Lacchini, J J Muniz, Y T D A Nobre, A J Cologna in The Pharmacogenomics Journal (2013)

  10. No Access

    Article

    Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia

    Studies showed elevated cell-free hemoglobin (Hb) in preeclampsia (PE), and Hb reacts with nitric oxide (NO), decreasing its bioavailability. Haptoglobin (Hp) is a polymorphic protein (Hp1-1, Hp2-1 and Hp2-2) ...

    J T Sertório, R Lacchini, L M Amaral, A C T Palei in Journal of Human Hypertension (2013)

  11. No Access

    Article

    Adiponectin associates positively with nitrite levels in children and adolescents

    To compare the circulating levels of adiponectin and nitric oxide (NO) bioavailability in eutrophic, eutrophic hypertensive, obese, and obese hypertensive children and adolescents, and to assess whether adipon...

    V A Belo, D C Souza-Costa, R Lacchini, J T Sertório in International Journal of Obesity (2013)

  12. No Access

    Article

    Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction

    Erectile dysfunction (ED) is usually treated with sildenafil. Although genetic polymorphisms in the endothelial nitric oxide synthase (eNOS) gene may impair endogenous NO formation, there is little information ab...

    J J Muniz, R Lacchini, T O Rinaldi, Y T D A Nobre in The Pharmacogenomics Journal (2013)

  13. No Access

    Article

    eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril

    The antihypertensive effect of angiotensin-converting enzyme inhibitors (ACEi) is attributed partially to increased nitric oxide bioavailability. It is possible that functional polymorphisms in endothelial nit...

    P. S. Silva, V. Fontana, M. R. Luizon in European Journal of Clinical Pharmacology (2013)

  14. No Access

    Article

    Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy

    Abnormal matrix metalloproteinase (MMP)-9 levels may have a role in hypertensive disorders of pregnancy. We examined whether MMP-9 genetic polymorphisms (g.−1562C>T and g.−90(CA)13−25) modify plasma MMP-9 and tis...

    A C T Palei, V C Sandrim, L M Amaral, J S R Machado in The Pharmacogenomics Journal (2012)

  15. No Access

    Article

    Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients

    Matrix metalloproteinases (MMPs) are involved in cardiac remodelling. We examined whether MMP-2 genetic polymorphisms are associated with hypertension and left ventricular (LV) remodelling in hypertensive pati...

    R Lacchini, A L B Jacob-Ferreira, M R Luizon, S Gasparini in Journal of Human Hypertension (2012)

  16. No Access

    Article

    Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction

    Erectile dysfunction (ED) may reflect vascular alterations associated with imbalanced matrix metalloproteinases (MMPs) activities. However, no previous study has compared MMPs levels in ED patients with those ...

    J J Muniz, R Lacchini, V A Belo in International Journal of Impotence Research (2012)